PT-141 vs oxytocin

Women who type these two names together have usually lost one of two things. One is the wanting, the spark that used to show up on its own. The other is the closeness, the easy warm feeling of being near someone you love. PT-141 is aimed at the first, oxytocin is bought for the second, and the useful question is which one sounds like you.

PT-141 is bremelanotide, approved by the FDA in 2019 as Vyleesi. It acts on desire in the brain rather than on blood flow, and it's taken as needed, not daily. The approval is precise, it covers premenopausal women with acquired, generalized low desire, meaning desire that was fine before and then dropped, that shows up across situations and partners, that causes real distress, and that isn't explained by another condition, the relationship or a medication. In the two large trials behind it, women on PT-141 reported more desire and less distress about it than women on placebo over 24 weeks. The gain was real and modest.

The label says plainly that it isn't for postmenopausal women. That doesn't mean it's known to fail after menopause, it means the trials enrolled women before menopause, so their results don't tell you what to expect after it. Women past menopause do use research vials, and what they describe is reported experience, not trial data.

Oxytocin is a hormone your brain makes during childbirth, breastfeeding and closeness. It's approved as Pitocin, a hospital drug for labor, and the research vials are bought for mood and feeling connected. Its main trial in women with sexual dysfunction run in 2015, had women before and after menopause use a 32 IU nasal spray before sex for 8 weeks and a placebo spray for another 8. Both stretches improved sexual function by about the same amount, so the trial couldn't credit the spray. A 2014 study of couples found a single spray didn't change sex drive or arousal. It raised orgasm intensity and contentment afterward, more in men than in women.

Our menopause and hormones page lists everything else women look at for the same goal.

Where these come from: every PT-141 figure except the vendor range is from the Vyleesi prescribing information, the two large trials behind its approval and an earlier dose-finding trial, and the 1 to 2 mg range is what vendor education pages and forums repeat, with no named clinician behind it. The oxytocin nasal amounts are from a 2011 review of 38 nasal spray trials, most of them single doses and most of the people in them men, and the 32 IU before-sex figure is from a 2015 trial in 30 women with sexual dysfunction. The units to draw and how long a vial lasts are on the PT-141 dosage chart. There's no oxytocin dosage page, because no study or label sets a pattern for mood or desire.

IU, or international units, measures a hormone's activity rather than its weight. Research oxytocin is sold by the milligram, so a study's IU figure means nothing for a vial until the vendor gives you its conversion.

People do pair them. Some compounding pharmacies and telehealth clinics list bremelanotide and oxytocin together on their product pages, sold by prescription, usually with tadalafil, the active ingredient in Cialis, as a lozenge that dissolves in the cheek or as a nasal spray. The sellers' own explanation is that each one covers a different piece: PT-141 for desire, oxytocin for closeness, tadalafil for blood flow.

That logic is the sellers', not a study's. No trial has tested the combination. People ask about stacking the research vials too, but no study or label sets an amount for either compound when they're paired. A compounded product also changes the math entirely, because a lozenge or spray isn't the 1.75 mg injection the PT-141 label describes.

1. Evolve BioPep10 mg · $20.00 $2.00/mg
2. Alpha Peptides10 mg · $23.17 $2.32/mg
3. Glow Aminos10 mg · $24.20 $2.42/mg
4. Flawless Compounds10 mg · $24.20 $2.42/mg
5. Next Gen Peptides10 mg · $24.99 $2.50/mg

1. Modern Aminos10 mg · $36.00 $3.60/mg
2. GhostLabz10 mg · $39.99 $4.00/mg
3. Simple Peptide10 mg · $45.00 $4.50/mg
4. Double R Labs5 mg · $24.99 $5.00/mg
5. LA Peptides10 mg · $49.99 $5.00/mg

Compare both in the app. Check the real price per milligram across vial sizes rather than the sticker on one vial, and think about how many doses you'll actually use in the 28 days after mixing, since neither is a daily habit for most people. Look for third-party purity and identity testing on the batch you'll get. Vendors on PPL carry confidence labels, from High confidence to New vendor, and our guide to research compounds and approved drugs explains what changes when the same molecule is both.

PT-141: as an approved drug, it has a measured side-effect list. Per the Vyleesi label, nausea was the most common, in 40% of women in the trials, and 13% needed medicine for it. For most women it eased by the second dose. Flushing, injection site reactions, headache and vomiting came next. PT-141 also raises blood pressure a little after each dose, up to about 6 points on the top number and 3 on the bottom, peaking 2 to 4 hours later and settling within 12 hours, and the label rules it out for uncontrolled high blood pressure or known heart disease. About 1% of women developed darker patches of skin on the face, gums or breasts, more often with darker skin and with daily use, and they didn't always fade. The label says to avoid it with oral naltrexone taken for alcohol or opioid addiction, and to use effective contraception while taking it.

Oxytocin: the 2011 review found no side effects that people could tell apart from a placebo spray at 18 to 40 IU, over single doses and short courses. Most of the people in those trials were men, most got a single dose, and nobody has studied years of use. Oxytocin makes the uterus contract, which is why it's given in pregnancy only in a hospital.

Together: no study has looked at how the two behave in combination, so there's no interaction data either way. A compounded product that adds tadalafil brings a third drug, one never approved for sexual use in women, with its own cautions. Its label rules it out for anyone taking nitrates for chest pain, and compounded products aren't FDA-reviewed the way Vyleesi is. With any research vial, the vial itself is the everyday risk, so the testing on the batch matters as much as the compound.

PT-141 has a label and a prescriber behind it as Vyleesi, and oxytocin has one only as Pitocin, for labor. Any vial of either bought online is sold for research. You knew that, it's why you're reading this and not the label.